# Ligand Pharmaceuticals Inc: Form SCHEDULE 13D, filed May 1, 2026

- Company: [Ligand Pharmaceuticals Inc](/companies/lgnd.md) (CIK 886163)
- Form: SCHEDULE 13D
- Filed: 2026-05-01
- Accepted by EDGAR: May 1, 2026, 21:15 ET
- Period: not reported
- Accession: 0001193125-26-202033
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/886163/000119312526202033/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/886163/000119312526202033/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/886163/000119312526202033/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-202033. Last ingested by Listed: Nov 7, 2026, 14:49 ET. No prices; not investment advice.